Detalhe da pesquisa
1.
A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors.
Invest New Drugs
; 38(4): 1067-1076, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471863